These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 8254666

  • 1. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S, Stouch T, Novotny J.
    J Mol Biol; 1993 Dec 05; 234(3):661-79. PubMed ID: 8254666
    [Abstract] [Full Text] [Related]

  • 2. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA, Lu SM, Ding J, Bateman KS, James MN, Anderson S, Song J, Markley JL, Ganz PJ, Saunders CW, Laskowski M.
    Biochemistry; 1999 Jun 01; 38(22):7142-50. PubMed ID: 10353824
    [Abstract] [Full Text] [Related]

  • 3. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS, Huang K, Anderson S, Lu W, Qasim MA, Laskowski M, James MN.
    J Mol Biol; 2001 Jan 26; 305(4):839-49. PubMed ID: 11162096
    [Abstract] [Full Text] [Related]

  • 4. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
    Huang K, Lu W, Anderson S, Laskowski M, James MN.
    Protein Sci; 1995 Oct 26; 4(10):1985-97. PubMed ID: 8535235
    [Abstract] [Full Text] [Related]

  • 5. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J, Jaskólski M, Buczek O, Cierpicki T, Czapińska H, Krowarsch D, Smalas AO, Stachowiak D, Szpineta A, Dadlez M.
    Acta Biochim Pol; 2001 Oct 26; 48(2):419-28. PubMed ID: 11732612
    [Abstract] [Full Text] [Related]

  • 6. Structural insights into the non-additivity effects in the sequence-to-reactivity algorithm for serine peptidases and their inhibitors.
    Lee TW, Qasim MA, Laskowski M, James MN.
    J Mol Biol; 2007 Mar 23; 367(2):527-46. PubMed ID: 17266986
    [Abstract] [Full Text] [Related]

  • 7. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA, Elrod K, Luong C, Rice MJ, Mackman RL, Sprengeler PA, Spencer J, Hataye J, Janc J, Link J, Litvak J, Rai R, Rice K, Sideris S, Verner E, Young W.
    J Mol Biol; 2001 Apr 13; 307(5):1451-86. PubMed ID: 11292354
    [Abstract] [Full Text] [Related]

  • 8. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
    Qasim MA, Van Etten RL, Yeh T, Saunders C, Ganz PJ, Qasim S, Wang L, Laskowski M.
    Biochemistry; 2006 Sep 26; 45(38):11342-8. PubMed ID: 16981694
    [Abstract] [Full Text] [Related]

  • 9. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
    Qasim MA, Ganz PJ, Saunders CW, Bateman KS, James MN, Laskowski M.
    Biochemistry; 1997 Feb 18; 36(7):1598-607. PubMed ID: 9048543
    [Abstract] [Full Text] [Related]

  • 10. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain.
    Lu W, Qasim MA, Laskowski M, Kent SB.
    Biochemistry; 1997 Jan 28; 36(4):673-9. PubMed ID: 9020764
    [Abstract] [Full Text] [Related]

  • 11. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK, Grossmann JG, Zaidi ZH.
    J Nat Toxins; 1999 Oct 28; 8(3):363-84. PubMed ID: 10591040
    [Abstract] [Full Text] [Related]

  • 12. Computational analysis of the binding of P1 variants of domain 3 of turkey ovomucoid inhibitor to Streptomyces griseus protease B.
    Fujinaga M, Huang K, Bateman KS, James MN.
    J Mol Biol; 1998 Dec 18; 284(5):1683-94. PubMed ID: 9878379
    [Abstract] [Full Text] [Related]

  • 13. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W, Apostol I, Qasim MA, Warne N, Wynn R, Zhang WL, Anderson S, Chiang YW, Ogin E, Rothberg I, Ryan K, Laskowski M.
    J Mol Biol; 1997 Feb 21; 266(2):441-61. PubMed ID: 9047374
    [Abstract] [Full Text] [Related]

  • 14. Predicting proteinase specificities from free energy calculations.
    Mekonnen SM, Olufsen M, Smalås AO, Brandsdal BO.
    J Mol Graph Model; 2006 Oct 21; 25(2):176-85. PubMed ID: 16386933
    [Abstract] [Full Text] [Related]

  • 15. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
    Apostoluk W, Otlewski J.
    Proteins; 1998 Sep 01; 32(4):459-74. PubMed ID: 9726416
    [Abstract] [Full Text] [Related]

  • 16. Binding of native and [homoserine lactone-52]-52,53-seco-bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor) to porcine pancreatic beta-kallikrein-B and bovine alpha-chymotrypsin: thermodynamic study.
    Oddone R, Barra D, Amiconi G, Ascenzi P, Tarricone C, Bolognesi M, Bortolotti F, Menegatti E.
    J Mol Recognit; 1994 Mar 01; 7(1):39-46. PubMed ID: 7527234
    [Abstract] [Full Text] [Related]

  • 17. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
    Czapinska H, Helland R, Smalås AO, Otlewski J.
    J Mol Biol; 2004 Dec 03; 344(4):1005-20. PubMed ID: 15544809
    [Abstract] [Full Text] [Related]

  • 18. Effects of eglin-c binding to thermitase: three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes.
    Gros P, Teplyakov AV, Hol WG.
    Proteins; 1992 Jan 03; 12(1):63-74. PubMed ID: 1553381
    [Abstract] [Full Text] [Related]

  • 19. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
    Krowarsch D, Dadlez M, Buczek O, Krokoszynska I, Smalas AO, Otlewski J.
    J Mol Biol; 1999 May 28; 289(1):175-86. PubMed ID: 10339415
    [Abstract] [Full Text] [Related]

  • 20. Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites.
    Capasso C, Rizzi M, Menegatti E, Ascenzi P, Bolognesi M.
    J Mol Recognit; 1997 May 28; 10(1):26-35. PubMed ID: 9179777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.